Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Open-market buy Director bought 10,000 shares at $1.66 ($16,600)
  2. 4 Open-market buy Director bought 10,000 shares at $1.80 ($17,999)
  3. 4 Open-market buy CEO bought 10,029 shares at $1.51 ($15,144)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Vice President sold 50,000 shares at an average $2.41 ($120,310)
  7. 4/A Open-market sale Vice President sold 30,571 shares at $2.22 ($67,868)
  8. 4 Open-market sale Vice President sold 30,571 shares at $2.22 ($67,868)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy CEO bought 25,000 shares at $0.53 ($13,250)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 18,100 shares at $0.49 ($8,869)
  16. 4 Open-market buy CEO bought 10,100 shares at an average $0.40 ($4,039)
  17. 4 Open-market buy CEO bought 4,800 shares at $0.37 ($1,776)
  18. 4 Open-market buy CEO bought 35,100 shares at an average $0.42 ($14,787)
  19. 4 Open-market buy Director bought 25,000 shares at $0.38 ($9,500)
  20. 4 Open-market sale Controller sold 11,334 shares at an average $0.99 ($11,221)

Page 12 of 18 · 341 filings